Level Four Advisory Services LLC Purchases 1,157 Shares of VanEck Pharmaceutical ETF (NASDAQ:PPH)

Level Four Advisory Services LLC increased its position in VanEck Pharmaceutical ETF (NASDAQ:PPH) by 3.7% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 32,017 shares of the company’s stock after purchasing an additional 1,157 shares during the period. Level Four Advisory Services LLC owned approximately 0.51% of VanEck Pharmaceutical ETF worth $2,762,000 at the end of the most recent quarter.

Other hedge funds have also bought and sold shares of the company. J.Safra Asset Management Corp grew its holdings in shares of VanEck Pharmaceutical ETF by 230.5% during the fourth quarter. J.Safra Asset Management Corp now owns 260,267 shares of the company’s stock valued at $22,391,000 after buying an additional 181,511 shares during the last quarter. Miller Investment Management LP boosted its stake in VanEck Pharmaceutical ETF by 13.4% during the 3rd quarter. Miller Investment Management LP now owns 207,535 shares of the company’s stock valued at $19,722,000 after purchasing an additional 24,446 shares during the last quarter. Mivtachim The Workers Social Insurance Fund Ltd. Under Special Management increased its holdings in VanEck Pharmaceutical ETF by 117.4% during the 4th quarter. Mivtachim The Workers Social Insurance Fund Ltd. Under Special Management now owns 200,000 shares of the company’s stock worth $17,256,000 after purchasing an additional 108,000 shares in the last quarter. Adamsbrown Wealth Consultants LLC raised its stake in shares of VanEck Pharmaceutical ETF by 102.3% in the fourth quarter. Adamsbrown Wealth Consultants LLC now owns 149,631 shares of the company’s stock worth $12,910,000 after purchasing an additional 75,659 shares during the last quarter. Finally, Independent Advisor Alliance lifted its holdings in shares of VanEck Pharmaceutical ETF by 19.8% in the fourth quarter. Independent Advisor Alliance now owns 58,398 shares of the company’s stock valued at $5,039,000 after purchasing an additional 9,647 shares in the last quarter.

VanEck Pharmaceutical ETF Trading Up 0.3 %

NASDAQ PPH opened at $90.65 on Friday. The business has a fifty day simple moving average of $90.74 and a 200 day simple moving average of $90.79. VanEck Pharmaceutical ETF has a 12 month low of $84.48 and a 12 month high of $99.51. The firm has a market capitalization of $565.66 million, a P/E ratio of 27.82 and a beta of 0.72.

About VanEck Pharmaceutical ETF

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.